氫氣和一氧化碳結合用於體外器官保護是最佳搭配

 


 


 


 


這個沒有摘要和全文,只有題目. 有具體內容後再修改. 這說明有人在進行這方面的探討.值得注意


Copyright © 2009 International Society for Heart and Lung Transplantation Published by Elsevier Inc.


Abstract


 


135: Combined Administration of Gas and Carbon Monoxide Is a Superior Strategy for Ameliorating Cardiac Cold Ischemia/Reperfusion Injury in Rats Hydrogen


 


Heart, Lung and Esophageal Surgery Institute, University of Pittsburgh, Pittsburgh, PA


COMBINED ADMINISTRATION OF HYDROGEN AND CARBON MONOXIDE IS ASUPERIORSTRATEGY FOR AMELIORATIONG CARDIAC COLD ISCHEMIA/REPERFUSION INJURY


Atsunori Nakao, David J Kaczorowski, Ryujiro Sugimoto, Jianghua Zhan, Yinna Wang, Kenneth R McCurry


 


Thomas E Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh


Department of Surgery, University of Pittsburgh


 


Background : Hydroxyl radicals, generated during ischemia/reperfusion injury (IRI), play a critical role in graft injury. Recently, it has been reported that hydrogen (H 2) gas alleviates oxidative injury by selectively neutralizing hydroxyl radicals. In this study, we evaluated the combined effects of H with carbon monoxide (CO), a molecule known to have anti-inflammatory and anti-apoptotic properties. 


Methods : Syngeneic, heterotopic HTx (LEW rats) was performed with 18 hrs of cold ischemia time. In the H 2or CO treated group, both donor and recipients were treated with H 2(2%) or CO (250 ppm) in air 1 hr before and 1 hr after reperfusion.


Results : In control (air) recipients, serum troponin I (TnI) and CPK levels increased within 3 hrs, but were significantly attenuated with H 2treatment. Cardiomyocyte apoptosis, prevalent in control grafts at 6 hrs, was also significantly attenuated with H 2.  H 2treatment resulted in significantly reduced MDA levels after transplant, demonstrating attenuated lipid peroxidation, and also reduced serum high-mobility group box-1 (HMGB1) levels. CO had marginal effects on preventing lipid peroxidation and myocardial oxidative injury. However, CO suppressed inflammatory responses, reducing graft mRNA levels for TNFα and serum IL-6, whereas H 2did not. These results suggest that H 2does not possess direct anti-inflammatory effects, but CO does. Conversely, while H 2has potent anti-oxidant properties, CO has marginal effects in scavenging radicals. Dual therapy with CO and H2demonstrated both anti-oxidant and anti-inflammatory effects. 


Conclusion : Mixed gas therapy with CO and H 2is a novel, safe and potent approach for preventing cardiac cold IRI.


Table. The effects of CO and hydrogen for cardiac cold I/R injury (*p<0.05 vs HTx/air)


 




























































 



TnI (3h)



CPK (IU/L, 3h)



TUNEL (6h)



MDA (3h)



HMGB1 (1h)



Serum IL-6 (3h)



normal



1.1



101



7.4



0.47



0.08



21



HTx (air)



224.7



15312



55.4



0.85



4.3



928.1



HTx (CO)



160.3



9171



35.2



0.83



3.8



462*



HTx (H 2)



80.5*



5458*



24.3*



0.65*



2.6



872.1



HTx (CO/H 2)



47.5*



4405*



22.1*



0.59*



2.7



206.4*



 


 


具體內容可以參考其一綜述:


J Clin Biochem Nutr. Click here to read Links2009 Jan;44(1):1-13. Epub 2008 Dec 27. 



Therapeutic antioxidant medical gas.


Nakao A Sugimoto R Billiar TR McCurry KR.

Thomas E Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA.


Medical gases are pharmaceutical gaseous molecules which offer solutions to medical needs and include traditional gases, such as oxygen and nitrous oxide, as well as gases with recently discovered roles as biological messenger molecules, such as carbon monoxide, nitric oxide and hydrogen sulphide. Medical gas therapy is a relatively unexplored field of medicine; however, a recent increasing in the number of publications on medical gas therapies clearly indicate that there are significant opportunities for use of gases as therapeutic tools for a variety of disease conditions. In this article, we review the recent advances in research on medical gases with antioxidant properties and discuss their clinical applications and therapeutic properties.


PMID: 19177183 [PubMed - in process]


PMCID: PMC2613492


 


 




Available online 24 January 2009. 


Article Outline


Purpose
Methods and Materials
Results
Conclusions

 


A. Nakao , DJ Kaczorowski , R. Sugimoto , J. Zhan , Y. Wang and KR McCurry a


 


 




 


台灣氫水實驗室 TEL:0963-210-763


 


email: ddh2water@gmail.com


 


台灣氫水實驗室部落格:http://blog.xuite.net/hworker77086600/twblog


 


歡迎來電索取氫水辨認方法(防止喝到傷身的假氫水) 


 


氫水,氫分子、氫氣、健康氫水,水素水,負電位,ORP,抗氧化,抗自由基,氫分子醫學,氫水,Hydrogen water,氫氣、氫,台灣氫水研究中心,氫思語,孫學軍,太田成男,鹼性離子水,小分子水,能量水,電解水,富氫水,負氫水,活水,健康,養生,活力,大氫鬆,小氫鬆,氫水機,水素,水素水機,王群光,氫氧機,綠加利,活美水素水,低氘水,活性原子氫,富氫水,負氫水,每日水素,活氫水,氫氧造水機,百樂,負氫,氫博士,氫水棒,氫源,新德美,HOH,鹼性活氫水,氫美機,負氫離子水,氫氣棒,呼吸氫氣,氫氧療法,加氫水,氫水、健康氫水、水素水、負電位、ORP、抗氧化、抗自由基 、氫分子醫學、氫水、Hydrogen water、氫氣、氫、氫水、台灣氫水實驗室、台灣氫水研究中心、氫思語、孫學軍、太田成男、鹼性離子水、小分子水、能量水、電解水、富氫水、負氫水、活水、健康、養生、活力、大氫鬆、小氫鬆、氫水機、水素、水素水機、王群光、氫氧機、綠加利、活美水素水、低氘水、活性原子氫、富氫水、負氫水、每日水素、活氫水、氫氧造水機、百樂、負氫、氫博士、氫水棒、氫源、新德美、HOH、鹼性活氫水、氫美機、負氫離子


 


提供玻璃瓶裝飽和氫水供對比,免費兩瓶給你測試,收運費120元。(運費是宅配業者收去的)


 


留言

這個網誌中的熱門文章

關於氫氣的純度,為何不能呼吸製氫機的氫氣?

"啾"的種類

"製氫機"的氫氣不但不能治病。有可能造成"中毒"與"腫瘤"的快速生長。請不要拿命開玩笑。